Literature DB >> 25664464

Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease.

Rachel F Buckley1, Kathryn A Ellis2, David Ames3, Christopher C Rowe4, Nicola T Lautenschlager5, Paul Maruff2, Victor L Villemagne4, S Lance Macaulay6, Cassandra Szoeke7, Ralph N Martins8, Colin L Masters2, Greg Savage9, Stephanie R Rainey-Smith8, Alan Rembach2, Michael M Saling10.   

Abstract

OBJECTIVE: To explore the subjective experience of memory change in groups at risk of dementia (those with mild cognitive impairment MCI or high β-amyloid (Aβ+) burden) to determine the existence of potential phenomenological typologies.
METHOD: We recruited 123 healthy controls (HC) and individuals with MCI from the Australian Imaging, Biomarker and Lifestyle (AIBL) study. Sixty-7 (HC = 47,MCI = 20) had Aβ scans available for analysis. Semistructured interviews were administered, transcribed, and meaningful phrases extracted from transcripts. Twelve themes were defined and compared across diagnostic status and Aβ status.
RESULTS: MCI endorsed more complaints of burdensome coping strategies, increasing frequency, sense of predomination, poor contextualization, progression, dependency, impact on affect, and dismissive attitudes. HCAβ+ acknowledged a progressive memory decline compared to HCAβ-, while MCIAβ+ expressed more burdensome coping strategies, dismissive attitudes, and dependency comparative to either healthy group. Depression was more likely to be related to complaint themes in HCs, while complaint themes were associated with poorer list-learning performance in individuals with MCI.
CONCLUSION: Complaint themes in those with MCI align with the MCI symptom complex, particularly when accompanied with high Aβ load. Healthy Aβ+ individuals acknowledged progressive memory change, suggesting they are aware of memory changes not yet detectable via neuropsychological measures. Depressive symptomatology associated with HC complaints, suggesting certain themes are affect-driven, while complaints in MCI are associated with organically driven functional impairment. Qualitative analysis of SMCs can inform the earliest clinical manifestations of Alzheimer's disease. Our findings can inform diagnostic approaches to the clinical evaluation of memory complaints in the nondemented elderly. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25664464     DOI: 10.1037/neu0000156

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  15 in total

1.  Memory complaints, dementia, and neuropathology in older blacks and whites.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Debra A Fleischman; Julie A Schneider; Kumar B Rajan; Jeremy J Pruzin; Raj C Shah; Denis A Evans; Lisa L Barnes; David A Bennett
Journal:  Ann Neurol       Date:  2018-03-30       Impact factor: 10.422

2.  Subjective Cognitive Decline Correlates With Depression Symptoms and Not With Concurrent Objective Cognition in a Clinic-Based Sample of Older Adults.

Authors:  Zvinka Z Zlatar; Martha Muniz; Douglas Galasko; David P Salmon
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2018-09-20       Impact factor: 4.077

3.  MicroRNA-135b has a neuroprotective role via targeting of β-site APP-cleaving enzyme 1.

Authors:  Yi Zhang; Hongxia Xing; Shuangxi Guo; Zhiyong Zheng; Haoliang Wang; Dawei Xu
Journal:  Exp Ther Med       Date:  2016-05-19       Impact factor: 2.447

4.  How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.

Authors:  Rhoda Au; Ryan J Piers; Sherral Devine
Journal:  Neuropsychology       Date:  2017-11       Impact factor: 3.295

5.  Implementation of subjective cognitive decline criteria in research studies.

Authors:  José L Molinuevo; Laura A Rabin; Rebecca Amariglio; Rachel Buckley; Bruno Dubois; Kathryn A Ellis; Michael Ewers; Harald Hampel; Stefan Klöppel; Lorena Rami; Barry Reisberg; Andrew J Saykin; Sietske Sikkes; Colette M Smart; Beth E Snitz; Reisa Sperling; Wiesje M van der Flier; Michael Wagner; Frank Jessen
Journal:  Alzheimers Dement       Date:  2016-11-05       Impact factor: 21.566

Review 6.  A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease.

Authors:  Rachel F Buckley; Victor L Villemagne; Colin L Masters; Kathryn A Ellis; Christopher C Rowe; Keith Johnson; Reisa Sperling; Rebecca Amariglio
Journal:  J Mol Neurosci       Date:  2016-08-11       Impact factor: 3.444

7.  Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance.

Authors:  Domilė Tautvydaitė; Deepti Kukreja; Jean-Philippe Antonietti; Hugues Henry; Armin von Gunten; Julius Popp
Journal:  Alzheimers Res Ther       Date:  2017-02-02       Impact factor: 6.982

8.  Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.

Authors:  Lisa Miebach; Steffen Wolfsgruber; Alexandra Polcher; Oliver Peters; Felix Menne; Katja Luther; Enise Incesoy; Josef Priller; Eike Spruth; Slawek Altenstein; Katharina Buerger; Cihan Catak; Daniel Janowitz; Robert Perneczky; Julia Utecht; Christoph Laske; Martina Buchmann; Anja Schneider; Klaus Fliessbach; Pascal Kalbhen; Michael T Heneka; Frederic Brosseron; Annika Spottke; Nina Roy; Stefan J Teipel; Ingo Kilimann; Jens Wiltfang; Claudia Bartels; Emrah Düzel; Laura Dobisch; Coraline Metzger; Dix Meiberth; Alfredo Ramirez; Frank Jessen; Michael Wagner
Journal:  Alzheimers Res Ther       Date:  2019-07-31       Impact factor: 6.982

9.  Cognitive changes following multiple-modality exercise and mind-motor training in older adults with subjective cognitive complaints: The M4 study.

Authors:  Narlon Cassio Boa Sorte Silva; Dawn P Gill; Adrian M Owen; Teresa Liu-Ambrose; Vladimir Hachinski; Ryosuke Shigematsu; Robert J Petrella
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

10.  Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data.

Authors:  R E Amariglio; S A M Sikkes; G A Marshall; R F Buckley; J R Gatchel; K A Johnson; D M Rentz; M C Donohue; R Raman; C-K Sun; R Yaari; K C Holdridge; J R Sims; J D Grill; P S Aisen; R A Sperling
Journal:  J Prev Alzheimers Dis       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.